Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain

Temple University logo

Temple University

Status and phase

Withdrawn
Phase 4

Conditions

Abdominal Cutaneous Nerve Entrapment Syndrome
Chronic Abdominal Wall Pain

Treatments

Drug: Lidocaine
Drug: Triamcinolone
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT02748395
23417

Details and patient eligibility

About

The purpose of this study is to determine whether the injection of triamcinolone and lidocaine is effective in relieving chronic abdominal wall pain.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of chronic abdominal wall pain
  • Prior ultrasound or cross-sectional imaging of the abdomen to exclude other causes
  • Baseline Brief Pain Inventory score ≥ 5

Exclusion criteria

  • Multiple trigger points
  • Abdominal wall hernia on exam
  • Weight loss
  • Rectal bleeding
  • Recent change in bowel habits
  • Decompensated cirrhosis or recurrent ascites
  • Allergy or contraindication to study medications
  • Known thrombocytopenia with platelet count < 50,000
  • Other diagnosis of chronic pain syndromes including fibromyalgia
  • Unable to provide informed consent
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Triple Blind

0 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Injection of 3.5mL of normal saline into the point of maximal tenderness in the abdomen
Treatment:
Other: Placebo
Treatment
Experimental group
Description:
Injection of 20mg triamcinolone and 1% lidocaine into the point of maximal tenderness in the abdomen
Treatment:
Drug: Triamcinolone
Drug: Lidocaine

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems